A drug commonly used to treat kidney cancer may increase the effectiveness of chemotherapy for mesothelioma, according to a study published in the May issue of the Journal of Thoracic Oncology. Temsirolimus, a kinase inhibitor, blocks the action of mammalian target of rapamycin (mTOR), a protein that regulates cell growth, which can slow tumor growth…
Asbestos / Mesothelioma News From Medical News Today Tags: AntiMesothelioma, Novel, Strategy
This entry was posted on November 15, 2011 at 1:41 am and is filed under Back Pain. You can follow any responses to this entry through the RSS 2.0 feed.
